Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.

FDA recall notice · announced May 20, 2020 · Masterpharm

Class I FDA/FSIS Class I: reasonable probability that use will cause serious adverse health consequences or death.

The product

Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419.

Reason for recall

Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.

Notes

Distribution: Nationwide in the U.S.
Lot/code information: Lot #02-27-2020:04@11, Exp. August 25, 2020.
Quantity: 7260 capsules
Status: Terminated
Products in this recall event:
- Finasteride Plus 1.25 mg Capsule, a) 30-count bottle, b) 90-count bottle, Compounded Product Not for Resale, MasterPharm, 115-02 Liberty Ave, Richmond Hill, NY 11419. (D-1269-2020)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.